New article in Nature Review in Rheumatology

Immune-checkpoint inhibitor use in patients with cancer and pre-existing autoimmune diseases

A giant step forward for the treatment of patients with PPR

New publication from LBAI-UMR1227 in JAMA: blocking IL-6 using tocilizumab has a strong steroid-sparing effect in Polymyalgia Rheumatica

New publication in Nature Communications

A new molecular classification to drive precision treatment strategies in primary Sjögren's syndrome

Machine learning identifies a common signature for anti-SSA/Ro60 antibody expression across autoimmune diseases

Autoantibodies are markers of autoimmune diseases. The most frequently observed is the anti-SSA/Ro autoantibody. It is observed in Gougerot-Sjögren syndrome, systemic lupus erythematosus, undifferentiated connectivites but also sometimes in rheumatoid arthritis and scleroderma. Using artificial intelligence approaches on multi-omics data [...]

Presentation of Anthony Mainguy, PhD student at LBAI

Anthony Mainguy joined the LBAI in 2020 to carry on a thesis project on the Implication of calcium signaling in the differentiation and functional orientation of the B lymphocyte. Watch a presentation video...